Anna M. Geretti

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications

Impact of HIV-1 RNA Assay Selection on Low-Level Viremia and Clinical Trial Endpoint Interpretations.

Impact of HIV-1 RNA Assay Selection on Low-Level Viremia and Clinical Trial Endpoint Interpretations.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 20, 2026

Hepatitis B virus prevalence, susceptibility and care engagement among vulnerable migrant populations in Rome.

Hepatitis B virus prevalence, susceptibility and care engagement among vulnerable migrant populations in Rome.

Journal: BMC infectious diseases
Published: February 17, 2026

Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus.

Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus.

Journal: The lancet. HIV
Published: February 10, 2026

Revisiting gonorrhoea prevention in the era of resistance and biomedical interventions.

Revisiting gonorrhoea prevention in the era of resistance and biomedical interventions.

Journal: Sexually transmitted infections
Published: January 05, 2026

Safety, pharmacokinetics, and pharmacodynamics of the antisense oligonucleotide RO7239958 in healthy volunteers and adults with chronic hepatitis B infection.

Safety, pharmacokinetics, and pharmacodynamics of the antisense oligonucleotide RO7239958 in healthy volunteers and adults with chronic hepatitis B infection.

Journal: Antimicrobial agents and chemotherapy
Published: November 04, 2025

Emergent HIV-1 Drug Resistance in Randomized Trials of Contemporary Antiretroviral Regimens.

Emergent HIV-1 Drug Resistance in Randomized Trials of Contemporary Antiretroviral Regimens.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 07, 2025

CROI 2025 BHIVA working group summary.

CROI 2025 BHIVA working group summary.

Journal: HIV medicine
Published: June 05, 2025

In conversation with Dr Paddy Horner.

In conversation with Dr Paddy Horner.

Journal: Sexually transmitted infections
Published: March 24, 2025

Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions.

Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions.

Journal: Open forum infectious diseases
Published: March 12, 2025

Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process.

Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process.

Journal: The lancet. HIV
Published: January 08, 2025

The Centenary Series - STIs Through the Ages: A Medical and Social Journey.

The Centenary Series - STIs Through the Ages: A Medical and Social Journey.

Journal: Sexually transmitted infections
Published: October 22, 2024

Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance- a phase IV randomised, open-label study (PIBIK study).

Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance- a phase IV randomised, open-label study (PIBIK study).

Journal: Virology journal
Published: October 11, 2024
Showing 1-12 of 120

Last Updated: 09/26/2026